Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
CUE
CUE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CUE News
Biotech Stocks Surge: Coherus Up 9.09% in After-Hours Trading
Jan 23 2026
NASDAQ.COM
IO Biotech (IOBT) Explores Strategic Alternatives, Stock Surges 19.36%
Jan 22 2026
NASDAQ.COM
Cue Biopharma Prices $10 Million Public Offering of Common Stock
Dec 19 2025
Globenewswire
Cue Biopharma Launches $10M Underwritten Public Offering; Stock Declines
Dec 19 2025
SeekingAlpha
Cue Biopharma Launches Underwritten Public Offering with 15% Additional Shares Option
Dec 18 2025
Globenewswire
Cue Biopharma Launches Underwritten Public Offering with 15% Additional Shares Option
Dec 18 2025
Newsfilter
Biotech Stocks Rise in After-Hours Trading Driven by Data Expectations and Momentum Buying
Dec 11 2025
NASDAQ.COM
Cue Biopharma (CUE) Price Target Raised by 25% to $5.10
Dec 06 2025
NASDAQ.COM
Healthcare and Biotech Stocks Surge in After-Hours Trading: Sensei, Praxis, Cooper, Vanda, Cue, ResMed
Dec 05 2025
NASDAQ.COM
ImmunoScape, Based in Singapore, Leads Development of Advanced Cell Therapy for Solid Tumors; Reveals Major Licensing Agreement and New Board and SAB Appointments
Nov 13 2025
Newsfilter
CervoMed Inc. (CRVO) Announces Q3 Loss and Falls Short of Revenue Projections
Nov 08 2025
NASDAQ.COM
Puma Biotech (PBYI) Exceeds Expectations with Q3 Earnings and Revenue
Nov 07 2025
NASDAQ.COM
LUCID CAPITAL MARKETS Begins Coverage of Cue Biopharma with a Buy Rating and Sets Price Target at $4
Aug 25 2025
Benzinga
Cue Biopharma Announces Initiation of Investigator Sponsored Trial of CUE-102 in Recurrent Glioblastoma Multiforme
Aug 13 2025
Newsfilter
High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds
Jul 23 2025
Newsfilter
Cue Biopharma Provides Update on Most Advanced Clinical Stage Asset, CUE-101, Presented by Dr. Dimitrios Colevas at the DAVA 4th Hawaii Global Summit on Thoracic Malignancies
Jul 01 2025
Newsfilter
Show More News
